Long-term effects of the COVID-19 pandemic on five mental and psychological disorders: in terms of the number of disease visits, drug consumption, and scale scores
Background COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the epidemic on people’s mental and psychological conditions, we surveyed in Wenzhou. Methods We collected the data of people who visited the Firs...
Saved in:
| Published in: | BMC psychiatry Vol. 23; no. 1; pp. 1 - 11 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
18.09.2023
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1471-244X, 1471-244X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the epidemic on people’s mental and psychological conditions, we surveyed in Wenzhou.
Methods
We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done.
Results
From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data.
Conclusion
The epidemic environment has had a long-term and negative impact on people’s mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. |
|---|---|
| AbstractList | BackgroundCOVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the epidemic on people’s mental and psychological conditions, we surveyed in Wenzhou.MethodsWe collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done.ResultsFrom 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data.ConclusionThe epidemic environment has had a long-term and negative impact on people’s mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people's mental health. To explore the impact of the epidemic on people's mental and psychological conditions, we surveyed in Wenzhou.BACKGROUNDCOVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people's mental health. To explore the impact of the epidemic on people's mental and psychological conditions, we surveyed in Wenzhou.We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done.METHODSWe collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done.From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data.RESULTSFrom 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data.The epidemic environment has had a long-term and negative impact on people's mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health.CONCLUSIONThe epidemic environment has had a long-term and negative impact on people's mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. Background COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the epidemic on people’s mental and psychological conditions, we surveyed in Wenzhou. Methods We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done. Results From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data. Conclusion The epidemic environment has had a long-term and negative impact on people’s mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people's mental health. To explore the impact of the epidemic on people's mental and psychological conditions, we surveyed in Wenzhou. We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done. From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data. The epidemic environment has had a long-term and negative impact on people's mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. Abstract Background COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the epidemic on people’s mental and psychological conditions, we surveyed in Wenzhou. Methods We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done. Results From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data. Conclusion The epidemic environment has had a long-term and negative impact on people’s mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. Background COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people's mental health. To explore the impact of the epidemic on people's mental and psychological conditions, we surveyed in Wenzhou. Methods We collected the data of people who visited the First Affiliated Hospital of Wenzhou Medical University for five types of mental and psychological diseases from January 2018 to December 2021. Then, taking December 2019 as the cut-off point, the 48-month data were divided into the pre-epidemic group and the dur-epidemic group. Based on the above data, statistical analysis was done. Results From 2018 to 2021, the number of initial diagnoses, the number of disease visits, and drug consumption for these five types of mental and psychological diseases were all on the rise. Compared with the number of disease visits for all disorders in both psychiatry and neurology departments, it was found that the growth rate of these five diseases was higher than the growth rate of all disorders. We found that the number of disease visits, drug consumption, and scale scores after the COVID-19 outbreak were significantly different from those before the outbreak (P < 0.05). And the number of disease visits positively correlated with drug consumption (P < 0.0001, r = 0.9503), which verified the stability of the data. Conclusion The epidemic environment has had a long-term and negative impact on people's mental and psychological conditions. Therefore, whether or not the epidemic is receding, we still need to be concerned about the impact of COVID-19 on mental and psychological health. Keywords: Mental and psychological diseases, The COVID-19 pandemic, Long-term effects, Epidemiology |
| ArticleNumber | 677 |
| Audience | Academic |
| Author | Guo, Yi-Mo Zhu, Ru-Huang Li, Zhang-Ping Wang, Zhen Pan, Zhi-Ming Zhu, Han-Yu Zhang, Meng-Li Wang, Yan |
| Author_xml | – sequence: 1 givenname: Han-Yu surname: Zhu fullname: Zhu, Han-Yu organization: Department of Neurology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital – sequence: 2 givenname: Yi-Mo surname: Guo fullname: Guo, Yi-Mo organization: The Second Clinical College, Wenzhou Medical University – sequence: 3 givenname: Zhi-Ming surname: Pan fullname: Pan, Zhi-Ming organization: Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, The First Clinical College, Wenzhou Medical University – sequence: 4 givenname: Yan surname: Wang fullname: Wang, Yan organization: Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, The First Clinical College, Wenzhou Medical University – sequence: 5 givenname: Meng-Li surname: Zhang fullname: Zhang, Meng-Li organization: Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, The First Clinical College, Wenzhou Medical University – sequence: 6 givenname: Ru-Huang surname: Zhu fullname: Zhu, Ru-Huang organization: Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical University – sequence: 7 givenname: Zhang-Ping surname: Li fullname: Li, Zhang-Ping email: wzlizhangping@126.com organization: The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital – sequence: 8 givenname: Zhen surname: Wang fullname: Wang, Zhen email: wangzhen@wzhospital.cn organization: Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University |
| BookMark | eNp9ks1u3CAUha0qlZqkfYGukLrpIk4B24C7qaJJf0YaKZu26g4xcPEQ2TAFe6Q8T1-0eCZtOlEVWcL25ZwPuJyz4sQHD0XxmuBLQgR7lwgVQpSYViVuCGMlflackpqTktb1j5N_vl8UZyndYky4aMhp8WsVfFeOEAcE1oIeEwoWjRtAi5vvy-uStGirvIHBaRQ8sm4HaAA_qh7lMtqmO70JfeiczhXjUogGYnqPnEcz9C_NT8Ma4vyXRaASoJ1LbkwXyMSpQzr4NA3b0QV_sQenzIM8hgjpZfHcqj7Bq_v3efHt08eviy_l6ubzcnG1KnUjmrGsqMJVbQzn63WrNKPYqFrrxtiWt42g1DLCKtxg1nIGmjDcEqaw4oRYak1bnRfLA9cEdSu30Q0q3smgnNwXQuykiqPTPUi7NgS3hlPR8ho3tTBQC8G1qDRja0oy68OBtZ3WAxidWxZVfwQ9nvFuI7uwk2TeIBEiE97eE2L4OUEa5eCShr5XHsKUJBWMVVwQPC_25pH0NkzR515lFed1WxHKHlRdbq103oa8sJ6h8oqzRtQ5PTyrLv-jys8-Azl11uX6kUEcDDqGlCJYqd2o5pvMRtfnA8k5ovIQUZk9ch9RibOVPrL-6c-TpupgSlnsO4gPh33C9RtUrPqO |
| CitedBy_id | crossref_primary_10_3389_fpubh_2025_1497197 crossref_primary_10_3390_jcm14020617 |
| Cites_doi | 10.1016/j.eclinm.2020.100289 10.1001/jamanetworkopen.2020.37665 10.1080/13607863.2019.1693969 10.1007/s11920-012-0282-y 10.1016/j.sleep.2020.04.019 10.1016/j.cbpra.2021.03.003 10.1038/mp.2015.188 10.1001/jama.2020.1097 10.1016/S0140-6736(21)02796-3 10.1136/bmj-2021-069317 10.1176/appi.ajp.2021.21040371 10.23750/abm.v91i1.9397 10.1002/da.23014 10.1111/pcn.12988 10.1016/j.jamda.2020.11.023 10.3390/ijerph17062032 10.1002/erv.2738 10.1111/j.1532-5415.1983.tb05748.x 10.1002/cncy.22364 10.1038/s41398-020-00949-5 10.1056/NEJMp2008017 10.1186/s13034-022-00482-x 10.1016/j.psychres.2010.07.040 10.17843/rpmesp.2020.374.6360 10.1002/eat.23317 10.1111/nmo.14092 10.1016/j.euroneuro.2021.05.009 10.1016/S0140-6736(20)30460-8 10.1186/s40337-020-00362-9 10.3109/09540261.2010.516427 10.1093/ije/dyaa033 10.15585/mmwr.mm6932a1 10.1016/j.jad.2022.05.084 10.5578/tt.20219711 10.1111/j.1528-1167.2005.463003.x 10.1016/j.psychres.2013.09.027 10.1016/S2215-0366(20)30046-8 10.5664/jcsm.8540 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023. BioMed Central Ltd., part of Springer Nature. BioMed Central Ltd., part of Springer Nature 2023 |
| Copyright_xml | – notice: The Author(s) 2023 – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023. BioMed Central Ltd., part of Springer Nature. – notice: BioMed Central Ltd., part of Springer Nature 2023 |
| DBID | C6C AAYXX CITATION 3V. 7TK 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PSYQQ Q9U 7X8 5PM DOA |
| DOI | 10.1186/s12888-023-05166-0 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Neurosciences Abstracts ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest - Psychology Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-244X |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_fbd109d7289740548de4887c83c66b21 PMC10506188 A765840237 10_1186_s12888_023_05166_0 |
| GeographicLocations | Syria China |
| GeographicLocations_xml | – name: Syria – name: China |
| GrantInformation_xml | – fundername: Institute Of Aging, Key Laboratory Of Alzheimer’s Disease Of Zhejiang Province grantid: none – fundername: ; grantid: none |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS AZQEC BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DWQXO E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GNUQQ GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IPY ITC KQ8 M1P M2M M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PSYQQ PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION 3V. 7TK 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c585t-32a034dd77bb9ac620da4cc5df9795822f61630506976ec160916a0a711f2fd93 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001069462200003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-244X |
| IngestDate | Fri Oct 03 12:34:12 EDT 2025 Tue Nov 04 02:06:18 EST 2025 Sun Nov 09 11:02:19 EST 2025 Thu Oct 09 21:52:41 EDT 2025 Sat Nov 29 14:13:56 EST 2025 Sat Nov 29 11:01:34 EST 2025 Sat Nov 29 01:38:56 EST 2025 Tue Nov 18 21:48:02 EST 2025 Sat Sep 06 07:21:58 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Mental and psychological diseases Epidemiology The COVID-19 pandemic Long-term effects |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c585t-32a034dd77bb9ac620da4cc5df9795822f61630506976ec160916a0a711f2fd93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2877493126?pq-origsite=%requestingapplication% |
| PQID | 2877493126 |
| PQPubID | 44775 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_fbd109d7289740548de4887c83c66b21 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10506188 proquest_miscellaneous_2866378101 proquest_journals_2877493126 gale_infotracmisc_A765840237 gale_infotracacademiconefile_A765840237 crossref_citationtrail_10_1186_s12888_023_05166_0 crossref_primary_10_1186_s12888_023_05166_0 springer_journals_10_1186_s12888_023_05166_0 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-09-18 |
| PublicationDateYYYYMMDD | 2023-09-18 |
| PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | BMC psychiatry |
| PublicationTitleAbbrev | BMC Psychiatry |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | WJ Bryson (5166_CR27) 2020; 16 PS Chandra (5166_CR35) 2010; 22 J Shigemura (5166_CR21) 2020; 74 AM Monteleone (5166_CR34) 2021; 51 M Bauer (5166_CR3) 2005; 46 FRE Smink (5166_CR4) 2012; 14 L Vuillier (5166_CR31) 2021; 9 JL Sommer (5166_CR39) 2021; 25 NC Peeri (5166_CR16) 2020; 49 B Nelson (5166_CR11) 2020; 128 NH Kalin (5166_CR28) 2021; 178 R Shafran (5166_CR18) 2021; 28 Y-T Xiang (5166_CR22) 2020; 7 SK Brooks (5166_CR24) 2020; 395 S Flynn (5166_CR36) 2011; 185 D Cucinotta (5166_CR6) 2020; 91 M Czeisler (5166_CR29) 2020; 69 L Steardo (5166_CR2) 2020; 10 X Cheng (5166_CR5) 2022; 311 A Phillipou (5166_CR32) 2020; 53 M Malta (5166_CR17) 2020; 20 M Czeisler (5166_CR30) 2021; 4 H İnönü Köseoğlu (5166_CR26) 2021; 69 S Gilsbach (5166_CR12) 2022; 16 B Pfefferbaum (5166_CR10) 2020; 383 KS Kendler (5166_CR1) 2016; 21 5166_CR20 T Roehrs (5166_CR38) 1983; 31 F Fernández-Aranda (5166_CR33) 2020; 28 AB Suthar (5166_CR8) 2022; 377 C Faravelli (5166_CR37) 2013; 210 R Maunder (5166_CR23) 2003; 168 K Fujita (5166_CR9) 2021; 22 L Sher (5166_CR19) 2020; 70 MB Stein (5166_CR15) 2020; 37 O Medina-Ortiz (5166_CR25) 2020; 37 G Oliviero (5166_CR13) 2021; 33 AL Phelan (5166_CR14) 2020; 323 Estimating excess mortality (5166_CR7) 2022; 399 |
| References_xml | – volume: 20 start-page: 100289 year: 2020 ident: 5166_CR17 publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100289 – volume: 4 start-page: e2037665 year: 2021 ident: 5166_CR30 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2020.37665 – volume: 25 start-page: 234 year: 2021 ident: 5166_CR39 publication-title: Aging Ment Health doi: 10.1080/13607863.2019.1693969 – volume: 14 start-page: 406 year: 2012 ident: 5166_CR4 publication-title: Curr Psychiatry Rep doi: 10.1007/s11920-012-0282-y – volume: 70 start-page: 124 year: 2020 ident: 5166_CR19 publication-title: Sleep Med doi: 10.1016/j.sleep.2020.04.019 – volume: 28 start-page: 459 year: 2021 ident: 5166_CR18 publication-title: Cogn Behav Pract doi: 10.1016/j.cbpra.2021.03.003 – volume: 21 start-page: 152 year: 2016 ident: 5166_CR1 publication-title: Mol Psychiatry doi: 10.1038/mp.2015.188 – volume: 323 start-page: 709 year: 2020 ident: 5166_CR14 publication-title: JAMA doi: 10.1001/jama.2020.1097 – volume: 399 start-page: 1513 year: 2022 ident: 5166_CR7 publication-title: Lancet doi: 10.1016/S0140-6736(21)02796-3 – volume: 377 start-page: e069317 year: 2022 ident: 5166_CR8 publication-title: BMJ doi: 10.1136/bmj-2021-069317 – volume: 178 start-page: 471 year: 2021 ident: 5166_CR28 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2021.21040371 – volume: 91 start-page: 157 year: 2020 ident: 5166_CR6 publication-title: Acta Biomed doi: 10.23750/abm.v91i1.9397 – volume: 37 start-page: 302 year: 2020 ident: 5166_CR15 publication-title: Depress Anxiety doi: 10.1002/da.23014 – volume: 74 start-page: 281 year: 2020 ident: 5166_CR21 publication-title: Psychiatry Clin Neurosci doi: 10.1111/pcn.12988 – volume: 22 start-page: 220 year: 2021 ident: 5166_CR9 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2020.11.023 – ident: 5166_CR20 doi: 10.3390/ijerph17062032 – volume: 168 start-page: 1245 year: 2003 ident: 5166_CR23 publication-title: CMAJ – volume: 28 start-page: 239 year: 2020 ident: 5166_CR33 publication-title: Eur Eat Disord Rev doi: 10.1002/erv.2738 – volume: 31 start-page: 364 year: 1983 ident: 5166_CR38 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1983.tb05748.x – volume: 128 start-page: 679 year: 2020 ident: 5166_CR11 publication-title: Cancer Cytopathol doi: 10.1002/cncy.22364 – volume: 10 start-page: 261 year: 2020 ident: 5166_CR2 publication-title: Transl Psychiatry doi: 10.1038/s41398-020-00949-5 – volume: 383 start-page: 510 year: 2020 ident: 5166_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMp2008017 – volume: 16 start-page: 46 year: 2022 ident: 5166_CR12 publication-title: Child Adolesc Psychiatry Ment Health doi: 10.1186/s13034-022-00482-x – volume: 185 start-page: 368 year: 2011 ident: 5166_CR36 publication-title: Psychiatry Res doi: 10.1016/j.psychres.2010.07.040 – volume: 37 start-page: 755 year: 2020 ident: 5166_CR25 publication-title: Rev Peru Med Exp Salud Publica doi: 10.17843/rpmesp.2020.374.6360 – volume: 53 start-page: 1158 year: 2020 ident: 5166_CR32 publication-title: Int J Eat Disord doi: 10.1002/eat.23317 – volume: 33 start-page: e14092 year: 2021 ident: 5166_CR13 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.14092 – volume: 51 start-page: 84 year: 2021 ident: 5166_CR34 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2021.05.009 – volume: 395 start-page: 912 year: 2020 ident: 5166_CR24 publication-title: Lancet doi: 10.1016/S0140-6736(20)30460-8 – volume: 9 start-page: 10 year: 2021 ident: 5166_CR31 publication-title: J Eat Disord doi: 10.1186/s40337-020-00362-9 – volume: 22 start-page: 513 year: 2010 ident: 5166_CR35 publication-title: Int Rev Psychiatry doi: 10.3109/09540261.2010.516427 – volume: 49 start-page: 717 year: 2020 ident: 5166_CR16 publication-title: Int J Epidemiol doi: 10.1093/ije/dyaa033 – volume: 69 start-page: 1049 year: 2020 ident: 5166_CR29 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6932a1 – volume: 311 start-page: 198 year: 2022 ident: 5166_CR5 publication-title: J Affect Disord doi: 10.1016/j.jad.2022.05.084 – volume: 69 start-page: 387 year: 2021 ident: 5166_CR26 publication-title: Tuberk Toraks doi: 10.5578/tt.20219711 – volume: 46 start-page: 4 year: 2005 ident: 5166_CR3 publication-title: Epilepsia doi: 10.1111/j.1528-1167.2005.463003.x – volume: 210 start-page: 1301 year: 2013 ident: 5166_CR37 publication-title: Psychiatry Res doi: 10.1016/j.psychres.2013.09.027 – volume: 7 start-page: 228 year: 2020 ident: 5166_CR22 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30046-8 – volume: 16 start-page: 1423 year: 2020 ident: 5166_CR27 publication-title: J Clin Sleep Med doi: 10.5664/jcsm.8540 |
| SSID | ssj0017851 |
| Score | 2.3808239 |
| Snippet | Background
COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the... Background COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people's mental health. To explore the impact of the... COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people's mental health. To explore the impact of the epidemic on... BackgroundCOVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact of the... Abstract Background COVID-19 caused mild to severe infections in humans. The long-term epidemic environment harms people’s mental health. To explore the impact... |
| SourceID | doaj pubmedcentral proquest gale crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1 |
| SubjectTerms | Analysis Antidepressants COVID-19 Development and progression Epidemics Epidemiology Evaluation Growth rate Health aspects Infection Long-term effects Medicine Medicine & Public Health Mental and psychological diseases Mental disorders Mental health Mental illness Psychiatry Psychotherapy Psychotropic drugs Statistical analysis Surveys Syria The COVID-19 pandemic |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxFMECjISEgfWapyHH9xKoQKpFA6AerNsxykrQbLa7PKH-KPMOM7SUAEXLqts7DiJZzz-JvZ8Q8hTV6jgvG4ZTM-OVbp1TNmyYnVtncQv-8FHdv0TeXqqzs70hwupvnBP2EgPPHbcQesanutGgmMgAVxUqgmgc9Kr0gvhYgh5AahncqbS-gGmnJ9CZJQ4GMAKg0bA_MRACQX40LNpKLL1X7bJl_dJ_rZYGueg45vkRgKP9HB86FvkSuhuk2vv0vL4HfLjpO_OGRpbmvZp0L6lAPHo0fvPb18xrukKPxp_W3rad7QFS0dHcn8Kp-nqojGkTeLlHF7QZUex0V1rYxoR_JfWdyiGqG-GBW3W23PqY1hntEWL2PAA7QX47cG3v0s-Hb_-ePSGpSwMzIMrsWFlYfOyahopndPWiyJvbOV93bRa6hrwRSsA0-V1LgDZBM8FIBBhcys5b4u20eU9stf1XbhPaOWRcDAEUQRRWZ27oMpWwkGprAdokhE-CcX4RFGOmTK-muiqKGFGQRoQpImCNHlGnu-uWY0EHX-t_RJlvauJ5NrxBKicSSpn_qVyGXmGmmLQBMDjeZsiGeAlkUzLHEqEdXBXmZH9WU0Yun5ePOmaSaZjMODCykqXvBAZebIrxitxO1wX-i3WAaAokZstI2qmo7M3m5d0yy-RPpyjrLhSGVlM6vzr7n_uugf_o-sekutFHIWacbVP9jbrbXhErvrvm-WwfhzH8E_RQ0f1 priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bjpUwsNHVGF-8b0RXUxMTHzyNlEsvvq2rG03W1XjZ7FsDpRxPonAC5_hD_qgzpaC4aqIvBOi0QDtXpjNDyMMyUa60umYgnkuW6bpkqkgzludFKfHPvrM-u_6RPD5Wp6f6bQgK68fd7qNL0nNqT9ZKPOmBk8KqgoxhgEgC7ODz5AKIO4Xk-O79yeQ7wHLzY3jMb_vNRJDP1H-WH5_dI_mLo9TLn8Or__fm18iVoG_S_QFBrpNzrrlBLr0OHvWb5NtR2ywZ8mcatnbQtqagFdKDNyevnjOu6Rr_M39ZWdo2tAbmSId6ABRu0_XP_JNWIZVn_5SuGoqDTqMNlUfwKriEKEa1b_oFrbrtklofCerZ18IP3MN4Do5t5_pb5OPhiw8HL1ko3MAsWB8bliZFnGZVJWVZ6sKKJK6KzNq8qrXUOagktQA1MM5jAcqQs1yA0iKKuJCc10ld6XSX7DRt424TmlnMUeicSJzICh2XTqW1hJNUFRa0mYjwcS2NDVnNsbjGZ-OtGyXMMPsGZt_42TdxRB5PfdZDTo-_Qj9DFJkgMR-3v9F2SxPI29RlxWNdSTBfJajAmaoccEZpVWqFKBMekUeIYAa5BryeLULwA3wk5t8y-xI1QXiqjMjeDBKo3c6bRxQ1gdv0BqxememUJyIiD6Zm7Ik76BrXbhEGdEuJ6dwiomaoPfuyeUuz-uQzjnNcK65URBYjhv94-p-n7s6_gd8llxNPJJpxtUd2Nt3W3SMX7dfNqu_ueyL_Dus7TRM priority: 102 providerName: Springer Nature |
| Title | Long-term effects of the COVID-19 pandemic on five mental and psychological disorders: in terms of the number of disease visits, drug consumption, and scale scores |
| URI | https://link.springer.com/article/10.1186/s12888-023-05166-0 https://www.proquest.com/docview/2877493126 https://www.proquest.com/docview/2866378101 https://pubmed.ncbi.nlm.nih.gov/PMC10506188 https://doaj.org/article/fbd109d7289740548de4887c83c66b21 |
| Volume | 23 |
| WOSCitedRecordID | wos001069462200003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库 customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest - Psychology Database customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: M2M dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-244X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017851 issn: 1471-244X databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZYhxAv3BGBURkJiQdqLbf6wgvaxiYmraUaMJUnK3GcUgmS0rT8If4o5zhuR5jYCy9WYztO3Bx__nz7DiEv81ja3KiSQfecs1SVOZNZkrLhMMsFzuxb49T1z8R4LKdTNfETbo3fVrnBRAfURW1wjnwfmL1IVRLF_O3iB0OvUbi66l1o7JBdVCpLe2T38Hg8Od-uI6Dr-c1RGcn3G0BjsAzopxgYI4exdKc7cqr9V7H56n7JvxZNXV90cvd_a3GP3PEslB60ZnOf3LDVA3Jr5NfZH5JfZ3U1Y4ja1G_4oHVJgSvSow8Xp-9YpOgCZ5-_zw2tK1oCZNLWSwCFaLr4E1Vp4QU-mzd0XlEsdFta648Er_xCEcWz7qtmQIvlekaNOx_qQG3gCm6gPAthvbTNI_L55PjT0Xvm3TkwA2OSFUviLEzSohAiz1VmeBwWWWrMsCiVUEMgKiUHchgOQw4UyZqIA5XhWZiJKCrjslDJY9Kr6so-ITQ1qFxoLY8tTzMV5lYmpYAficwMcJyARJuvqo3XOkeXG9-0G_NIrltL0GAJ2lmCDgPyenvPolX6uDb3IRrLNieqdLuIejnTvtHrMi-iUBUCBrUCiHEqCwt4KYxMDOd5HAXkFZqaRiyB1zOZPxIBlURVLn0gkB_CU0VA9jo5AQNMN3ljbtpjUKMvbS0gL7bJeCfuq6tsvcY8wDgFirwFRHaMvFOzbko1_-p0yCP8VpGUARls2sPl0__91z29_mWfkduxa6CKRXKP9FbLtX1Obpqfq3mz7JMdMRUulH3f2PtuHgXCUTyCuMnpaPIFrs4_XvwGlq5e0Q |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqgoALb0SggJFAHFircR62g4RQaam66nbhUNDeTOI4y0qQLJtdEL-HO7-RGSfZEip664HLKhs7TuKMv2_GHs8Q8iQLlM1MUjCg54xFSZExlYYRi-M0kzizb42Lrj-S47GaTJJ3G-RXtxcG3So7THRAnVcG58i3QbOXURLyQLyaf2WYNQpXV7sUGo1YHNof38Fkq18O9-D7Pg2C_TfHuweszSrADKjGSxYGqR9GeS5lliWpEYGfp5ExcV4kMomBLwsBOoof-wKY2hougFFF6qeS8yIocgy-BJB_AXBcoguZnKwNPJfovtuYo8R2DdgPcgisyED0BVjuPfJzOQJOM8Fp78y_lmgd8-1f-9_67Dq52urYdKcZFDfIhi1vkktHrRfBLfJzVJVThpxEW3cWWhUUNGG6-_bDcI_xhM5xbv3LzNCqpAUQAm1yIFA4Ted_cgbN2_Cl9Qs6Kyk2um6tybaC_9plMIo7-Zf1gOaL1ZQat_vVQfbANVxDexZ-q4Wtb5P359JFd8hmWZX2LqGRwbiM1orAiihN_MyqsJBwEKrUgAbnEd5JkTZtJHdMKPJZO4tOCd1IngbJ007ytO-R5-tr5k0ckzNrv0bhXNfEGOTuRLWY6hbSdJHl3E9yCSa7BLU_UrkFNpBGhUaILOAeeYairREp4fFM2m74gJfEmGN6R6L2C3eVHtnq1QSEM_3iTrx1i7C1PpFtjzxeF-OV6DVY2mqFdUCflhjCziOqN6h6b9YvKWefXJR1jt-KK-WRQTf-Tu7-7667d_bDPiKXD46PRno0HB_eJ1cCBw4J42qLbC4XK_uAXDTflrN68dBBCyUfz3tc_gbZfbHl |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgoIkXvhGBAUZC4oFai5PUH7yNjYqJUiYB096sxLFLJUiqJuUf4h_lzknLwgAJ8VKl8dmJ7fP5Luf7HSHPikS5wmrPYHsuWKZ9wVSeZmw8zguJX_adDej6UzmbqbMzfXIuij-cdt-4JLuYBkRpqtr9Zem7Ja7EfgNSFWYY9hsGTCXAJr5MrmSYNAjt9Q-nWz8Cpp7fhMr8tt5gOwqo_Rdl88Xzkr84TcNeNLnx_724Sa73eig96BjnFrnkqttk913vab9Dvk_ras5QbtP-yAetPQVtkR6-Pz0-YlzTJX5__rqwtK6oB6FJuzwBFG7T5Xm5Ssse4rN5SRcVxUa3rXUZSfBf7yqiGO3eNiNartZzakOEaBBro9BwA-05-K1XrrlLPk1efzx8w_qEDsyCVdKyNMnjNCtLKYtC51YkcZln1o5Lr6Ueg6riBaiH8TgWoCQ5ywUoMyKPc8m5T3yp03tkp6ord5_QzCJ2oXMicSLLdVw4lXoJF6nKLWg5EeGbeTW2RzvHpBtfTLB6lDDd6BsYfRNG38QRebGts-ywPv5K_QrZZUuJON3hRr2am37ZG1-UPNalBLNWgmqcqdKBxJRWpVaIIuEReY7MZlCawOvZvA-KgE4iLpc5kKghwlNlRPYGlCAF7LB4w66ml0KNAWtYZjrliYjI020x1sSTdZWr10gDOqdEmLeIqAGbD3o2LKkWnwMSOce54kpFZLTh9p9P__PQPfg38idk9-RoYqbHs7cPybUkrBfNuNojO-1q7R6Rq_Zbu2hWj8Pa_wF2eFjb |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+effects+of+the+COVID-19+pandemic+on+five+mental+and+psychological+disorders%3A+in+terms+of+the+number+of+disease+visits%2C+drug+consumption%2C+and+scale+scores&rft.jtitle=BMC+psychiatry&rft.au=Zhu%2C+Han-Yu&rft.au=Guo%2C+Yi-Mo&rft.au=Pan%2C+Zhi-Ming&rft.au=Wang%2C+Yan&rft.date=2023-09-18&rft.pub=BioMed+Central+Ltd&rft.issn=1471-244X&rft.eissn=1471-244X&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12888-023-05166-0&rft.externalDocID=A765840237 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-244X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-244X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-244X&client=summon |